Amanote Research
Register
Sign In
Pathological Assessment of Mediastinal Lymph Nodes in Lung Cancer: Implications for Non-Invasive Mediastinal Staging.
Thorax
- United Kingdom
doi 10.1136/thx.48.5.584
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pulmonary
Respiratory Medicine
Date
May 1, 1993
Authors
S H Ren
S J Xu
Publisher
BMJ
Related search
Minimally Invasive Mediastinal Staging of Non-Small Cell Lung Cancer
Precision and Future Medicine
Mediastinal Staging for Lung Cancer
Canadian Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
In Surgical Treatment of Non-Small-Cell Lung Cancer a Minimum Number of Resected Mediastinal Lymph Nodes Is Mandatory for Accurate Staging
Surgical Science
Commentary: Invasive Mediastinal Staging for Lung Cancer—Quality Gap, Evidence Gap, Both?
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Commentary: Invasive Mediastinal Staging for Lung Cancer Patients – We Need to Do Better!
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Vascular Image Patterns of Lymph Nodes for the Prediction of Metastatic Disease During EBUS-TBNA for Mediastinal Staging of Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Thoroughness of Mediastinal Staging in Stage IIIA Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Effect of Mediastinal Lymph Nodes Sampling in Patients With Clinical Stage I Non-Small Cell Lung Cancer
Journal of Medical Investigation
Biochemistry
Medicine
Genetics
Molecular Biology
Optimal Sequence of Tests for the Mediastinal Staging of Non-Small Cell Lung Cancer
BMC Medical Informatics and Decision Making
Health Policy
Health Informatics